» Authors » Filippo Maria Verardi

Filippo Maria Verardi

Explore the profile of Filippo Maria Verardi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 42
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Erriquez A, Colaiori I, Hakeem A, Guiducci V, Menozzi M, Barbierato M, et al.
Am Heart J . 2025 Feb; 284:71-80. PMID: 39984150
Background: Complete revascularization has been shown to be superior to culprit-only treatment in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease. However, it remains unclear whether complete revascularization...
2.
Galante D, Vicere A, Marrone A, Verardi F, Viccaro V, Giuliana C, et al.
Int J Cardiol . 2025 Jan; 422:132978. PMID: 39800227
Aims: To investigate the influence of index of microcirculatory resistance (IMR) on fractional flow reserve (FFR) and adenosine-induced hyperemia (ΔPd/Pa-FFR) in patients with chronic (CCS) or stabilized acute coronary syndromes...
3.
Leone A, Galante D, Vicere A, Marrone A, Verardi F, Giuliana C, et al.
Eur Heart J . 2025 Jan; 46(10):978-980. PMID: 39791532
No abstract available.
4.
Erriquez A, Campo G, Guiducci V, Casella G, Menozzi M, Cerrato E, et al.
JACC Cardiovasc Interv . 2024 May; 17(12):1425-1436. PMID: 38752972
Background: The role of quantitative flow ratio (QFR) in the treatment of nonculprit vessels of patients with myocardial infarction (MI) is a topic of ongoing discussion. Objectives: This study aimed...
5.
Biscaglia S, Verardi F, Erriquez A, Colaiori I, Cocco M, Cantone A, et al.
JACC Cardiovasc Interv . 2023 Oct; 17(2):277-287. PMID: 37902150
Background: The debate surrounding the efficacy of coronary physiological guidance compared with conventional angiography in achieving optimal post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) values persists. Objectives: The primary...
6.
Scala A, Erriquez A, Verardi F, Marrone A, Scollo E, Trichilo M, et al.
J Clin Med . 2023 Sep; 12(18). PMID: 37762785
The present study investigates the prognostic value of the Syntax Score II 2020 corrected for flow-limiting lesions and its ability to better address treatment by benefit prediction among patients with...
7.
Bujak K, Verardi F, Arevalos V, Gabani R, Spione F, Rajwa P, et al.
EuroIntervention . 2023 Aug; 19(8):664-675. PMID: 37533321
Background: Controversy still exists regarding the optimal treatment of coronary bifurcation lesions. Aims: We aimed to analyse the evidence from randomised controlled trials (RCTs) to compare outcomes following different bifurcation...
8.
Verardi F, Bujak K, Tolomeo P, Gomez-Lara J, Jimenez-Diaz V, Jimenez M, et al.
Rev Esp Cardiol (Engl Ed) . 2023 Jul; 77(3):215-225. PMID: 37506972
Introduction And Objectives: After ST-segment myocardial infarction (STEMI), the impact of different adverse events on prognosis remains unknown. We aimed to assess very long-term predictors of patient-oriented composite endpoints (POCE)...
9.
Biscaglia S, Verardi F, Tebaldi M, Guiducci V, Caglioni S, Campana R, et al.
JACC Cardiovasc Interv . 2023 Mar; 16(7):783-794. PMID: 36898939
Background: Post-percutaneous coronary intervention (PCI) quantitative flow ratio (QFR) values ≥0.90 are associated with a low incidence of adverse events. Objectives: The AQVA (Angio-based Quantitative Flow Ratio Virtual PCI Versus...
10.
Erriquez A, Uretsky B, Brugaletta S, Spitaleri G, Cerrato E, Quadri G, et al.
Int J Cardiovasc Imaging . 2022 Nov; 38(12):2819-2827. PMID: 36445673
To test whether quantitative flow ratio (QFR)-based trans-stent gradient (TSG) is associated with adverse clinical events at follow-up. A post-hoc analysis of the multi-center HAWKEYE study was performed. Vessels post-PCI...